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Abstract: The first total synthesis of (–)-huperzine W (1) has been achieved. Key element of the synthesis is a highly convergent 
assemblage for the two rings system of target molecule utilizing an efficient Suzuki-Miyaura coupling reaction between chiral  
iodide 2 and 2-allylpyrrolidinone 4. Evaluation of the AchE inhibition of synthetic huperzine W was also carried out. 
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Introduction 
The Lycopodium alkaloids1 are a diverse group of structurally
complex natural products. Owing both to their appealing,  
synthetically challenging polycyclic systems with dense  
stereochemical array and wide-ranging biological activities, a 
wealth of total synthesis of Lycopodium alkaloids have been 
reported.2 In the context of our ongoing synthetic endeavor on 
a complex polycyclic Lycopodium alkaloid,3 huperzine W, an 
unusual structure-simplified natural Lycopodium alkaloid  
attracted our attention. Huperzine W, isolated in 2002 along 
with alopecuridine by Zhu4 and co-workers from the plant of 
Huperzia serrata, is a novel 14 carbons Lycopodium alkaloid 
whose structure consists of a chiral cyclohexenone unit and a 
2-pyrrolidinone moiety, linked by three carbon atoms. We 
were attracted to a synthesis of huperzine W not only because 
it has not yet to be synthesized, albeit architecturally rather 
simple, but also due to our interesting observation that the 
unique backbone of huperzine W is embedded delicately in the 
more intriguing polycyclic systems of other Lycopodium  
alkaloids (see Figure 1), such as 8-deoxyserratinine,3b,3c,5  
serratinine6 and serratezomine A.7 In principle, a step-
economical and ideal synthesis of huperzine W, no doubt, will 
facilitate the total synthesis of the above complex alkaloids. 
Besides, we have a question about the biological activity of 
huperzine W, because its congener huperzine A is a well-
known potent inhibitor of the enzyme acetylcholinesterase 
(AchE) used for the treatment of Alzheimer’s disease.8 
 
Results and Discussion 
Our retrosynthetic analysis of huperzine W (1) is outlined in 
Scheme 1. We conjectured that an intermolecular Suzuki-
Miyaura cross-coupling9 of 2-allylpyrrolidinone 4 with iodide 
2 would directly furnish the target molecule with just one  
single step. Both iodide 2 and 2-allylpyrrolidinone 4 are 
known compounds.10 Iodide 2 was envisioned to arise from the 
optical cyclohexenone 3 and 2-allylpyrrolidinone 4 was  
prepared from pyrrolidinone 5 by N-alkylation. 
Our synthesis commenced with the preparation of the two 
fragments. As shown in scheme 2, upon treatment with iodide 
and pyridine, the starting material enone 3, prepared in 
multigram quantities according to the Caine’s method,11 
smoothly yielded the -iodo enone 2. On the other hand,  
2-allylpyrrolidinone 4 can be prepared quantitatively through 
N-alkylation of pyrrolidinone 5 (NaH, allyl bromide). 
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Hydroboration of the 2-allylpyrrolidinone 4 with 9-BBN, then 
the in situ generated trialkylborane intermediate (not shown) 
was reacted with -iodo enone 2 under the standard Suzuki-
Miyaura coupling conditions gave (–)-huperzine W (1) in 75% 
yield. All spectroscopic data matched those reported for the 
natural material. Our synthetic huperzine W (1) shows [α]25D   – 
33 (c 1.28, CHCl3), while the [α]D value of the natural 
huperzine W is unavailable for comparison. 
Since the biological activity of huperzine W has not been 
documented in the isolation paper, we still wondered whether 
huperzine W might be active in inhibition of acetylcholines-
terase (AChE), hoping to associate it with the potent huperzine 
A; and then evaluation of the AchE inhibition of synthetic 
huperzine W was performed. Unfortunately, this structural 
simplified Lycopodium alkaloid entirely lacks any activity in 
inhibition of AChE (see Table 1),12 suggesting the unique 
chemical structure of huperzine A is not replaceable and  
essential for its pronounced bioactivity. 
In summary, the one-step and first asymmetric total synthesis
of huperzine W was realized by a highly convergent route 
using an efficient Suzuki-Miyaura coupling reaction between 
chiral iodide 2 and 2-allylpyrrolidinone 4. This step-
economical synthesis is potentially beneficial to the synthesis 
of other relevant complex Lycopodium alkaloids. 
 
Experimental Section 
General Experimental Procedures. All reactions were 
performed with dry solvents under anhydrous conditions,  
unless otherwise noted. Dry tetrahydrofuran (THF) were  
distilled over sodium-potassium alloy. Dichloromethane and 
dimethylformamide (DMF) were distilled over calcium  
hydride. Yields refer to chromatographically and spectroscopi-
cally homogeneous materials, unless otherwise noted.  
Reagents were used as received without further purification, 
unless otherwise stated. Silica gel (200–300 mesh, Qingdao 
Marine Chemical Ltd., China), light petroleum ether (bp 60–
90 ºC), ethyl acetate and methanol were used for product  
purification by flash column chromatography. NMR spectra 
were recorded in CDCl3 solution on Bruker AV-400  
instrument with tetramethylsilane (TMS) as an internal  
reference. IR spectra were recorded with KBr pellets on a 
Bruker Tensor 27 FT-IR spectrometer. Optical rotations were 
determined on a Jasco P-1020 digital polarimeter. High-
resolution mass spectral analysis (HRMS) data were recorded 
via electron impact mass spectrometry using a time of flight 
analyzer. 
 
Iodide (2). To a solution of the optical cyclohexenone 3 
(2.24 g, 20.3 mmol) in CH2Cl2 (200 mL) were added pyridine 
(20.7 mL, 257.8 mmol) and iodine (8.29 g, 32.5 mmol) at 0 C. 
The mixture was allowed to raise to room temperature over 1 h. 
After 8 h, the mixture was diluted with CH2Cl2 and washed 
successively with 2N aqueous HCl, H2O, saturated aqueous 
sodium hydrogen carbonate solution and saturated aqueous 
sodium thiosulfate solution. The organic phase was dried over 
sodium sulfate and concentrated. The crude product was  
purified by silica gel column chromatography (petroleum 
ether/ethyl acetate 50:140:1) to afford iodide 2 (4.08 g, 85% 
yield) as a white solid. [α]25D   – 82 (c 4.04, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ ppm: 7.69 (dd, J = 5.6, 2.8 Hz, 1H), 
2.76–2.65 (m, 1H), 2.49–2.39 (m, 1H), 2.32–2.21 (m, 2H), 
2.18–2.09 (m, 1H), 1.04 (d, J = 6.0 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ ppm: 192.5, 158.6, 103.4, 45.0, 37.9, 30.3, 
20.6; IR (KBr) max cm–1: 2958, 2923, 1684, 1589, 879, 549; 
HRMSEI m/z: calcd for C7H9IO [M]+: 235.9698, found 
235.9697. 
 
2-Allylpyrrolidinone (4). To a suspension of sodium 
hydride (890 mg, 70% oil dispersion, 26.0 mmol) in THF (100 
mL) was added slowly a solution of pyrrolidinone 5 (2.02 g, 
23.6 mmol) in THF (100 mL) at 0 C. The mixture was stirred 
for 1 h at 0 C under argon atmosphere. Then allyl bromide 
(2.7 mL, 30.7 mmol) was added slowly at 0 C. Then the 
mixture was stirred overnight at 75 C. The reaction was 
quenched with saturated aqueous ammonium chloride solution 
and extracted with ethyl acetate. The combined organic extract 
was washed with brine, dried over sodium sulfate and 
concentrated. The crude product was purified by silica gel 
column chromatography (petroleum ether/ethyl acetate 
2:11:1) to afford 2-allylpyrrolidinone 4 (3.53 g, 100% yield) 
as a colorless oil. 1H NMR (400 MHz, CDCl3) δ ppm: 5.64–
5.52 (m, 1H), 5.08–5.01 (m, 2H), 3.75 (d, J = 5.6 Hz, 2H), 
3.23 (t, J = 7.2 Hz, 2H), 2.27 (t, J = 8.0 Hz, 2H), 1.94–1.84 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ ppm: 174.6, 132.3, 117.6, 
46.6, 45.0, 30.8, 17.6; IR (KBr) max cm–1: 2920, 1687, 1661, 
1643, 1496, 1464, 1442, 1419, 1270, 1202, 996. HRMSEI m/z: 
calcd for C7H11NO [M]+:125.0841, found 125.0833. 
 
 
Scheme 1.  Retrosynthetic analysis of huperzine W 
 
Scheme 2.  Synthesis of huperzine W 
Table 1. The AChE inhibitory activity of huperzine A, tacrine 
and huperzine W 
Compound Concentration (M) Inhibition Rate (%) 
Huperzine A 0.025 53 
Tacrine 0.33 49 
Huperzine W 100 2.3
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(–)-Huperzine W (1). To a solution of 2-allylpyrrolidinone 
4 (202 mg, 1.6 mmol) in THF (10 mL) was added a solution of 
9-BBN (4.3 mL, 0.5 N, 2.1 mmol) at room temperature. After 
stirring for 4 h at room temperature, the mixture was treated 
with degassed water (0.44 mL) and transferred via cannula to a 
mixture of iodide 2 (251 mg, 1.1 mmol), Pd(dppf)Cl2 (87 mg, 
0.11 mmol), AsPh3(33 mg, 0.11 mmol) and Cs2CO3 (658 mg, 
2.0 mmol) in degassed DMF (3 mL). The mixture was stirred 
at room temperature for 1 h. Then the reaction was quenched 
with saturated aqueous ammonium chloride solution and 
extracted with ethyl acetate. The combined organic extract was 
washed with water, dried over sodium sulfate and concentrated. 
The crude product was purified by silica gel column 
chromatography (ethyl acetate/methanol 20:1) to afford ()-
Huperzine W 1 (187 mg, 75% yield) as a pale yellow oil. [α]25D   
– 33 (c 1.28, CHCl3); 1H NMR (400 MHz, CDCl3) δ ppm: 6.65 
(br. d, J = 2.4 Hz, 1H), 3.34–3.27 (m, 2H), 3.20–3.13 (m, 2H), 
2.42–2.24 (m, 4H), 2.15–2.01 (m, 3H), 2.02–1.87 (m, 4H), 
1.58–1.47 (m, 2H), 0.95 (d, J = 6.0 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ ppm: 199.7, 175.0, 145.5, 138.3, 47.0, 46.6, 
42.0, 34.3, 31.1, 30.6, 26.9, 26.2, 21.2, 17.9. IR (KBr) max 
cm–1: 2954, 2926, 1674, 1461, 1428, 1381, 1287, 1116, 1091, 
1040, 922, 904. HRMSEI m/z: calcd for C14H21NO2 [M]+: 
235.1572, found 235.1583. 
 
Inhibition of AChE Activity Assays. The AChE inhibitory 
activity of synthetic (–)-Huperzine W 1 was assayed by the 
colorimetric method of Ellman.13 Acetylthiocholine iodide 
(ATC), 5,5-Dithiobis(2-nitrobenzoic acid) (DTNB), tacrine 
and AChE were purchased from Sigma. AchE (0.4 U/mL), 
ATC (6.25 mM) and DNTB (6.25 mM) were dissolved in 
0.1M phosphate buffer (pH 8.0, respectively). Inhibitors (100 
M) were dissolved in dimethyl sulfoxide. The final dimethyl 
sulfoxide in all assays were maintained at 0.1% (v/v), including
controls. Inhibitor solution (10 L) and AChE (40 L) were 
mixed in a test tube, and the tube was set on the incubator (30 
C). To the tube were added DTNB (20 L), buffer (110 L), 
and ATC (20 L). The mixture was incubated at 30 C for 30 
min. The absorbance at 405 nm was measured spectrophoto-
metrically. All test and control assays were corrected by 
blanks for nonenzymic hydrolysis. All experiments were done 
in triplicate with tacrine as a positive control. 
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